Results 131 to 140 of about 1,385 (191)

Expanding access to postpartum long-acting reversible contraception (LARC): how can we deliver? [PDF]

, 2019
Michelle Cooper
openalex   +1 more source

Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use

HIV Medicine, Volume 26, Issue 6, Page 870-878, June 2025.
Abstract Introduction Integrase strand transfer inhibitors (INSTIs) are the mainstay of treatment in adults and children living with HIV. Weight gain has been associated with INSTI use in adults; however, less data exist on its effects on younger patients.
Kathleen J. Pincus, Nabila Faridi, Patrick Amadeus Ryscavage, Hyunuk Seung, Kristine A. Parbuoni, Matthew Grant, Neha Sheth Pandit   +6 more
wiley   +1 more source

“I am forced to just give it to her because she is the one who wants it”: A qualitative study of providers’ perspectives on contraceptive counseling in Tanzania

SSM: Qualitative Research in Health
Drawing on 29 in-depth interviews with health care providers in Dar es Salaam, Tanzania, this paper describes providers’ attitudes and beliefs about contraceptive methods and the extent to which providers consider client choice and autonomy when ...
Alexandra Wollum, Jessica D. Gipson, Amon Sabasaba, Mohamad I. Brooks, Corrina Moucheraud   +4 more
doaj  

How do women and health care professionals view hormonal long-acting reversible contraception? Results from an international survey [PDF]

, 2019
Thomas Faustmann, John Crocker, Carsten Moeller, Yvonne Engler, Cecilia Caetano, Kai J. Bühling   +5 more
openalex   +1 more source

Efficacy and safety of drospirenone as a progestin‐only pill in Japanese women: A phase III study

Journal of Obstetrics and Gynaecology Research, Volume 51, Issue 6, June 2025.
Abstract Aim To evaluate the efficacy and safety of 4 mg of drospirenone (DRSP), a progestin‐only pill (POP), for contraception in Japanese women. Methods This was a multicenter, open‐label, single‐arm study. The dosing period of DRSP was 13 cycles, each lasting for 28 days. In one cycle, 4 mg of DRSP was administered orally once daily for the first 24 
Kunio Kitamura, Enrico Colli, Ryoko Kikuyama, Yumiko Kurihara, Rieko Azuma, Tomoya Kagawa   +5 more
wiley   +1 more source

Who uses long-acting reversible contraception? Profile of LARC users in the CUPID cohort

, 2016
Jacqueline Coombe, Melissa L. Harris, Deborah Loxton   +2 more
openalex   +2 more sources

The narrative governance of life: Morality, melodrama, and the limits of biopower in western Indian efforts against sex selection

Medical Anthropology Quarterly, Volume 39, Issue 2, June 2025.
Abstract Selective abortion of female fetuses is a widespread, illegal, and profoundly consequential form of family planning in contemporary India. In Gujarat state, public health campaigns against the practice rely on narratives exhibiting the hallmarks of melodrama: good–evil binaries, stock characters, emotional provocations, simplistic diagnoses ...
Utpal N. Sandesara
wiley   +1 more source

What qualities of long-acting reversible contraception do women perceive as desirable or undesirable? A systematic review

, 2016
Jacqueline Coombe, Melissa L. Harris, Deborah Loxton   +2 more
openalex   +2 more sources

Making Contraception Accessible Through Implementation of Immediate Postpartum Long-Acting Reversible Contraception [PDF]

, 2019
Tania Fenner
openalex   +1 more source

Immediate Postpartum Long-Acting Reversible Contraception: Review of Insertion and Device Reimbursement Policies

, 2021
Charlan D. Kroelinger, Ekwutosi M. Okoroh, Keriann Uesugi, Lisa Romero, Olivia R. Sappenfield, Julia Howland, Shanna Cox   +6 more
openalex   +2 more sources